Nutrition and respiratory disease

Clinical Nutrition

Volumn 20, Issue SUPPL. 1, 2001, Pages 173-179

  Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anabolic stimulus; Chronic inflammation; Chronic obstructive pulmonary disease; Energy expenditure; Muscle strength; Nutritional support

Indexed keywords

PROTEIN;

ARTICLE; BODY MASS; CALORIC INTAKE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; CONTROLLED STUDY; DIETARY INTAKE; ENERGY BALANCE; ENERGY EXPENDITURE; EXERCISE; HUMAN; METABOLISM; MORTALITY; MUSCLE FUNCTION; NUTRITION; NUTRITIONAL SUPPORT; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SKELETAL MUSCLE; WEIGHT REDUCTION;

EID: 0034921095     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2001.0412     Document Type: Article

References (69)

1. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders
2. Peripheral muscle weakness contributes to exercise limitation in COPD
3. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
4. Skeletal muscle weakness is predominantly the consequence of extremity fat-free mass wasting but not of airflow obstruction in patients with chronic obstructive pulmonary disease
5. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease
6. Nutritional state and exercise tolerance in patients with COPD
7. Effect of reduced body weight on muscle aerobic capacity in patients with COPD
8. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
9. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease
10. Elevated iosine monophosphate levels in resting muscle of patients with stable COPD
11. A preliminary report on the effects of malnutrition on skeletal muscle composition in chronic obstructive pulmonary disease
12. Diaphragm and body weight in emphysema
13. Expiratory flow limitation in COPD patients after single lung transplantation
14. Body composition and health-related quality of life in patients with obstructive airways disease
15. Tissue depletion and health related quality of life patients with chronic obstructive pulmonary disease
16. Weight changes in the terminal stages of chronic obstructive pulmonary disease
17. Body weight in chronic obstructive pulmonary disease
18. Nutritional status and mortality in chronic obstructive pulmonary disease
19. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
20. Prognostic value of nutritional status in chronic obstructive pulmonary disease
21. Early nonelective readmission for chronic obstructive pulmonary disease is associated with weight loss
22. Acute exacerbations in patients with COPD: Predictors of need for mechanical ventilation
23. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD
24. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation
25. Different patterns of chronic tissue wasting among emphysema and chronic bronchitis patients
26. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function
27. Oxygen cost of breathing in patients with emphysema or chronic bronchitis in acute respiratory failure
28. The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease
29. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty
30. Breathing efficiency during inspiratory threshold loading in patients with chronic obstructive pulmonary disease
31. The cost of breathing in stable chronic obstructive pulmonary disease
32. Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects
33. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects
34. Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects
35. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease
36. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients
37. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
38. Increased resting energy expenditure is related to plasma TNF-alpha concentration in stable COPD patients
39. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease
40. Enhanced levels of whole body protein turnover in patients with chronic obstructive pulmonary disease
41. Respiratory muscle performance in normal elderly subjects and patients with COPD
42. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease
43. The daily energy expenditure in stable chronic obstructive pulmonary disease
44. Decreased mechanical efficiency in clinically stable patients with COPD
45. Decreased mechanical efficiency in clinically stable patients with COPD
46. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease
47. TNF-alpha and hypermetabolism in COPD
48. The nutritional status of patients with chronic obstructive pulmonary disease
49. Energy balance in chronic obstructive pulmonary disease
50. Transcutaneous oxygen saturation and carbon dioxide tension during meals in patients with chronic obstructive pulmonary disease
51. Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmonary disease patients
52. Circulating leptin in patients with chronic obstructive pulmonary disease
53. Plasma leptin is related to pro-inflammatory status and dietary intake in patients with COPD
54. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
55. Nutritional intervention in malnourished patients with emphysema
56. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic pulmonary disease patients
57. The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease
58. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary diseases, a randomized control study
59. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease
60. Dietary supplementation and respiratory muscle performance in patients with COPD
61. Nutritional repletion in malnourished patients with emphysema
62. The effect of an aggressive support regimen on body composition in patients with severe COPD and weight loss
63. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial
64. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD
65. The influence of an acute disease exacerbation on the metabolic and inflammatory profile in patients with COPD
66. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease
67. Characterization of non-response to high-caloric oral nutritional therapy in depleted patients with COPD
68. Tumor necrosis factor inhibits human myogenesis in vitro
69. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated-NF-kappaB activation in response to tumor necrosis factor alpha